| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |